Latest

Coronavirus

·April 16, 2020·3 min read

Proteins may halt the severe cytokine storms seen in COVID-19 patients

Researchers have designed antibody-like receptor proteins that can bind to cytokines, possibly reducing the effects of the COVID-19 associated cytokine storm.

Featured Neuroscience Open Neuroscience Articles

·April 16, 2020·3 min read

Development of antibody research may help prevent sepsis induced by COVID-19

Researchers have developed a novel antibody strategy to prevent the association between a harmless protein and a disease mediator that could lead to sepsis, and ultimately death. The findings could help to prevent sepsis induced by COVID-19 infections.

This shows a woman in a facemask holing a flower

Featured Neuroscience Open Neuroscience Articles

·April 16, 2020·3 min read

Study identifies 275 ways to reduce spread of coronavirus following lockdown

Study identifies 275 ways to help reduce the transmission of COVID-19 when countries eventually attempt to reduce social distancing pract

Featured Neuroscience Open Neuroscience Articles

·April 16, 2020·3 min read

Indoor precautions essential to stem airborne COVID-19

Researchers urge health officials to recognize and inform the public that airborne transmission of COVID-19 from droplets expelled by an infected person can spread beyond six feet. The study reports ventilation systems in cruises could have spread the virus between passengers. Measures to reduce indoor viral airborne transmission are proposed.

Featured Neuroscience Open Neuroscience Articles

·April 15, 2020·4 min read

COVID-19: Exercise may protect against deadly complication

Regular exercise may help prevent or reduce the severity of ARDS for those with coronavirus. A single session of exercise increases the production of a critical antioxidant, called EcSOD, helping to reduce the effects of COVID-19 infection.

This is a drawing of a person coughing in the chamber

Featured Neuroscience Neuroscience Videos

·April 15, 2020·3 min read

COVID-19: ‘Cough chamber’ shows six-feet not far enough

Droplets from a cough travel at a speed of 1.2 meters per second at peak velocity. Findings reveal that there is no logical reason to suggest 6 foot of physical distance is substantial at reducing coronavirus transmission.

Featured Neuroscience

·April 14, 2020·5 min read

Ultraviolet LEDs effective at eliminating coronavirus from surfaces, air and water

Researchers are developing new ultraviolet LEDs that can clean surfaces contaminated with COVID-19. The LEDs will also be able to purify air and water that contain coronavirus.

Featured Neuroscience

·April 14, 2020·4 min read

Targeting cell’s own machinery in fight against COVID-19

Coronaviruses rely on the TOP3B enzyme as a host factor, researchers report. Using artificial intelligence and molecular modeling, researchers were able to identify drug candidates that could serve as TOP3B inhibitors. Studies are now underway to test the drug candidates against living cell cultures and viruses, including COVID-19.

This shows covid19 and a depressed woman

Featured Neurology Neuroscience Open Neuroscience Articles Psychology

·April 14, 2020·4 min read

In wake of COVID-19 pandemic, a crashing wave of neuropsychiatric problems?

Reviewing data from past pandemics, researchers suggest some of those exposed to COVID-19 could have an increased risk of developing neurological and mental health disorders in the long term. Acute viral infections can result in encephalopathy, psychosis, depression, demyelination disorders, and problems with neuromuscular function.

This shows how to perform the sickstick test

Featured Neuroscience Neuroscience Videos

·April 14, 2020·4 min read

Scientists developing COVID-19 test that knows you’re sick before you do

Researchers are developing a self-diagnostic test for coronavirus and other viral infections. SickStick tests for nucleic acids in saliva that increase within hours of exposure to a virus.

This shows the interaction between dpp4 and covid19

Featured Genetics Neuroscience Open Neuroscience Articles

·April 13, 2020·2 min read

Could inhibiting the DPP4 enzyme help treat coronavirus?

Previous studies of related coronaviruses SARS and MERS found blocking DPP4 activity reduced inflammatory response. Researchers suggest drugs that target DPP4 could help to reduce the overexpression of inflammatory cytokines seen in severe COVID-19.

Featured Neuroscience

·April 13, 2020·4 min read

Remdesivir effective against a key enzyme of coronavirus that causes COVID-19

Remdesivir, a drug initially developed to fight Ebola and currently being fast-tracked into trials for COVID-19, is highly effective at stopping the replication mechanism of coronavirus. The drug tricks the virus by mimicking its building blocks, causing the inhibitor to get incorporated repeatedly, and preventing replication of SARS-CoV-2.